Annual report pursuant to Section 13 and 15(d)

Revenue Information (Tables)

v3.19.1
Revenue Information (Tables)
12 Months Ended
Dec. 31, 2018
Segment Reporting [Abstract]  
Schedule of Revenue by Product Lines

  Revenue by product lines was as follows:

 

    Years Ended  
    December 31,  
Product Line   2018     2017  
MicroParticle Catalyzed Biosensor (“MPC”)   $ 123,941     $ 381,228  
Particle ImmunoFiltration Assay (“PIFA”)     1,422,361       2,232,684  
Rapid Enzymatic Assay (“REA”)     68,750       133,848  
Other     50,518       556,952  
Product Revenue Total     1,665,570       3,304,712  
License Fees     -       50,000  
Total Revenue   $ 1,665,570     $ 3,354,712  

Schedule of Revenue by Geographic Area Determined Based On Location of Customers

The total revenue by geographic area determined based on the location of the customers was as follows:

 

    Years Ended  
    December 31,  
Geographic Region   2018     2017  
United States   $ 1,576,765     $ 2,679,549  
People’s Republic of China     -       502,131  
Rest of World     88,805       173,032  
Total Revenue   $ 1,665,570     $ 3,354,712